SurgoCap Partners LP — CARPENTER TECHNOLOGY CORP CRS: Quarterly 13F Position History
SurgoCap Partners LP has reported CARPENTER TECHNOLOGY CORP (CRS) on 7 13F-HR filings in Pactolio's tracked window, first appearing in Q3 2024. As of Q1 2026, the position is sized at 1,196,901 shares ($471.8M market value, 15.75% of the equity book). Quarter-over-quarter share count change: + 44,295 (+3.8%) .
- 1,196,901Shares Held (Latest Filing)
- $471.8MReported Market Value (Latest Filing)
- 15.75%Portfolio Weight (% of 13F Equity Book)
- +44,295Quarter-over-Quarter Share Change
- +$108.9MQuarter-over-Quarter Value Change
- 1,612,000Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 7 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,196,901 | +44,295 | +3.8% | $471.8M | 15.75% | $394.15 |
| Q4 2025 | 1,152,606 | 46,289 | -3.9% | $362.9M | 10.05% | $314.84 |
| Q3 2025 | 1,198,895 | +272,896 | +29.5% | $294.4M | 8.35% | $245.54 |
| Q2 2025 | 925,999 | 686,001 | -42.6% | $255.9M | 9.81% | $276.38 |
| Q1 2025 | 1,612,000 | +169,931 | +11.8% | $292.1M | 14.43% | $181.18 |
| Q4 2024 | 1,442,069 | +779,357 | +117.6% | $244.7M | 14.17% | $169.71 |
| Q3 2024 | 662,712 | — | — | $105.8M | 5.64% | $159.58 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did SurgoCap Partners LP first disclose a CRS position in 13F-HR filings?
SurgoCap Partners LP first reported CARPENTER TECHNOLOGY CORP (CRS) on its 13F-HR filing for the period ending 2024-09-30 (Q3 2024). The position has appeared on 7 reported quarters within Pactolio's tracked window.
What was SurgoCap Partners LP's most recent quarter-over-quarter share-count change in CRS?
Between Q4 2025 and Q1 2026, SurgoCap Partners LP added 44,295 shares of CRS (+3.8%), bringing the total reported position to 1,196,901 shares at a market value of $471.8M.
Does the implied price-per-share represent SurgoCap Partners LP's cost basis in CRS?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.